Dr. Georgios Rossidis, MD

Dr. Rossidis practices at HCA Florida Ocala Hospital in Ocala, Florida, part of HCA Healthcare.

Dr. Rossidis' NPI, 1912128646, was assigned on May 1, 2007. Dr. Rossidis graduated from Semmelweis University in 2004. Dr. Rossidis holds Florida license ME113218.

Dr. Rossidis' primary practice is HCA Florida Ocala Hospital, at 1431 SW 1st Ave, Ocala, FL 34471 in Marion County. The practice phone is (352) 401-1000.

Dr. Rossidis' primary practice is HCA Florida Ocala Hospital in Ocala, Florida, part of HCA Healthcare. The medical group on file is HCA Florida Ocala Surgical Group. Dmand AI also links Dr. Rossidis to 1 more home health agency, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rossidis practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Rossidis' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Rossidis is board certified in surgery by the American Board of Surgery. Dr. Rossidis is licensed in Florida.

Dmand AI lists abdominal hernia repair surgery, acute gallbladder or bile duct inflammation, appendectomy, colon removal, esophagus, stomach, or upper small intestine surgery, gallbladder removal, groin hernia surgery and hemorrhoids among the conditions Dr. Rossidis treats.

CMS data shows 474 Medicare services from Dr. Rossidis across 16 procedure codes in 2024, for 256 Medicare patients. Medicare paid $74,235 for them.

CMS counts 256 Medicare patients who saw Dr. Rossidis in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.38, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rossidis' median patient age at 69, with 66% women.

In 2024, Dr. Rossidis wrote 299 Medicare Part D claims for 228 patients. 100% of them were for generic drugs. CMS names the drug for 252 of them, across 3 drugs with 11 or more claims each, at $1,724 in total drug cost. In 2023, CMS named 260 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rossidis for performance year 2024, reported individually. Dr. Rossidis accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of hernia repair (minimally invasive) by Dr. Rossidis, more than 83% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Rossidis, published from 2011 to 2016. 2014 was the busiest year, with 3. The most frequent topics are Esophageal Neoplasms, Esophagectomy and Laparoscopy. Dr. Rossidis has published most often in J Gastrointest Surg. Dr. Rossidis' most frequent co-authors are Kfir Ben-David, MD, Steven Norbert Hochwald, MD and Angel Miguel Caban, MD.

CMS Open Payments shows 148 general payments to Dr. Rossidis from 36 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 49% of the total. Intuitive Surgical, Inc. paid the most, $4,889.

Dmand AI lists 2 awards for Dr. Rossidis, most recently CMS Stage 1 EHR in 2013.

Dr. Rossidis graduated from Semmelweis University in 2004. Dr. Rossidis is a member of ACS.

Dr. Rossidis is in network with 17 carriers, including Aetna, United Healthcare and Cigna. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.